Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Production of a Recombinant Anti-Human CD4 Single-Chain Variable-Fragment Antibody Using Phage Display Technology and Its Expression in Escherichia coli

  • Received : 2010.10.11
  • Accepted : 2011.03.02
  • Published : 2011.05.28
Download PDF
⟨ Previous Next ⟩

Abstract

Single-chain variable fragment (scFv) is a fusion protein of the variable regions of the heavy (VH) and light (VL) chains of immunoglobulin, connected with a short linker peptide of 10 to about 20 amino acids. In this study, the scFv of a monoclonal antibody against the third domain of human CD4 was cloned from OKT4 hybridoma cells using the phage display technique and produced in E. coli. The expression, production, and purification of anti-CD4 scFv were tested using SDS-PAGE and Western blot, and the specificity of anti-CD4 scFv was examined using ELISA. A 31 kDa recombinant anti-CD4 scFv was expressed and produced in bacteria, which was confirmed by SDS-PAGE and Western blot assays. Sequence analysis proved the ScFv structure of the construct. It was able to bind to CD4 in quality ELISA assay. The canonical structure of anti-CD4 scFv antibody was obtained using the SWISS_MODEL bioinformatics tool for comparing with the scFv general structure. To the best of our knowledge, this is the first report for generating scFv against human CD4 antigen. Engineered anti-CD4 scFv could be used in immunological studies, including fluorochrome conjugation, bispecific antibody production, bifunctional protein synthesis, and other genetic engineering manipulations. Since the binding site of our product is domain 3 (D3) of the CD4 molecule and different from the CD4 immunological main domain, including D1 and D2, further studies are needed to evaluate the anti-CD4 scFv potential for diagnostic and therapeutic applications.

Keywords

References

  1. Arbabi-Ghahroudi, M., J. Tanha, and R. MacKenzie. 2005. Prokaryotic expression of antibodies. Cancer Metastasis Rev. 24: 501-519. https://doi.org/10.1007/s10555-005-6193-1
  2. Benjamin, R. J. and H. Waldmann. 1986. Induction of tolerance by monoclonal antibody therapy. Nature 320: 449-451. https://doi.org/10.1038/320449a0
  3. Bird, R. E., K. D. Hardman, J. W. Jacobson, S. Johnson, B. M. Kaufman, and S. M. Lee. 1988. Single-chain antigen-binding proteins. Science 242: 423-426. https://doi.org/10.1126/science.3140379
  4. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254. https://doi.org/10.1016/0003-2697(76)90527-3
  5. Burastero, S. E., M. Figini, B. Frigerio, P. Lusso, L. Mollica, and L. Lopalco. 2009. Protective versus pathogenic anti-CD 4 immunity: Insights from the study of natural resistance to HIV infection. J. Trans. Med. 7: 101. https://doi.org/10.1186/1479-5876-7-101
  6. Burkly, L. C., D. Olson, R. Shapiro, G. Winkler, J. J. Rosa, D. W. Thomas, C. Williams, and P. Chisholm. 1992. Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIVinduced cell fusion. J. Immunol. 149: 1779.
  7. Cabilly, S. 1989. Growth at sub-optimal temperatures allows the production of functional, antigen-binding Fab fragments in Escherichia coli. Gene 85: 553-557. https://doi.org/10.1016/0378-1119(89)90451-4
  8. Carmen, S. and L. Jermutus. 2002. Concepts in antibody phage display. Brief. Funct. Genomics 1: 189. https://doi.org/10.1093/bfgp/1.2.189
  9. Carrel, S., A. Moretta, G. Pantaleo, G. Tambussi, P. Isler, B. Perussia, and J. C. Cerottini. 1988. Stimulation and proliferation of CD4+ peripheral blood T lymphocytes induced by an anti- CD4 monoclonal antibody. Eur. J. Immunol. 18: 333-339. https://doi.org/10.1002/eji.1830180303
  10. Chester, K. A., R. H. J. Begent, L. Robson, P. A. Keep, R. B. Pedley, J. A. Boden Libiol, et al. 1994. Phage libraries for generation of clinically useful antibodies. The Lancet 343: 455- 456. https://doi.org/10.1016/S0140-6736(94)92695-6
  11. Glockshuber, R., M. Malia, I. Pfitzinger, and A. Plückthun. 1990. A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry 29: 1362. https://doi.org/10.1021/bi00458a002
  12. Gutstein, N. L., W. E. Seaman, J. H. Scott, and D. Wofsy. 1986. Induction of immune tolerance by administration of monoclonal antibody to L3T4. J. Immunol. 137: 1127.
  13. Hasler, P. 2006. Biological therapies directed against cells in autoimmune disease Springer Seminars in Immunopathology 27: 443-456.
  14. Huston, J. S., D. Levinson, M. Mudgett-Hunter, M. S. Tai, J. Novotny, and M. N. Margolies. 1988. Protein engineering of antibody binding sites: Recovery of specific activity in an antidigoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 85: 5879-5883. https://doi.org/10.1073/pnas.85.16.5879
  15. Jabado, N., A. Pallier, F. Le Deist, F. Bernard, A. Fischer, and C. Hivroz. 1997. CD4 ligands inhibit the formation of multifunctional transduction complexes involved in T cell activation. J. Immunol. 158: 94.
  16. Jameson, B. A., P. E. Rao, L. I. Kong, B. H. Hahn, G. M. Shaw, L. E. Hood, and S. B. Kent. 1988. Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science 240: 1335. https://doi.org/10.1126/science.2453925
  17. Janeway, C. A., P. Travers, M. Walport, and M. Shlomchik. 2005. Immunobiology: The Immune System in Health and Disease. Garland Science Publishing, New York, USA.
  18. Kramer, K. and B. Hock. 2003. Recombinant antibodies for environmental analysis. Anal. Bioanal. Chem. 377: 417-426. https://doi.org/10.1007/s00216-003-2161-1
  19. Laemmli, U. K. 1970. Most commonly used discontinuous buffer system for SDS electrophoresis. Nature 227: 680-685. https://doi.org/10.1038/227680a0
  20. McCafferty, J., H. Hoogenboom, and D. Chiswell. 1996. Antibody Engineering: A Practical Approach. Oxford University Press, USA.
  21. Morgenthaler, N. G., K. Hodak, J. Seissler, H. Steinbrenner, I. N. A. Pampel, M. Gupta, A. M. McGregor, W. A. Scherbaum, and J. P. Banga 1999. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: A comparison to radioreceptor assay and thyroid stimulating bioassay. Thyroid 9: 467-475. https://doi.org/10.1089/thy.1999.9.467
  22. Peitsch, M. C. 1995. Protein modeling by e-mail. From amino acid sequence to protein structure: A free one-hour service. Nature Biotechnol. 13: 658-698. https://doi.org/10.1038/nbt0795-658
  23. Peitsch, M. C. and N. Guex. 1997. Swiss-Model and the Swiss- PDBViewer: An environment for comparative protein modeling. Electrophoresis 18: 2714-2723. https://doi.org/10.1002/elps.1150181505
  24. Peterson, A. and B. Seed. 1988. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell 54: 65-72.
  25. Qiagen. 2001. QIAgen Detection and Assay Handbook. Qiagen, Hilden, Germany.
  26. Qin, S. X., S. Cobbold, R. Benjamin, and H. Waldmann. 1989. Induction of classical transplantation tolerance in the adult. J. Exp. Med. 169: 779. https://doi.org/10.1084/jem.169.3.779
  27. Saerens, D., F. Frederix, G. Reekmans, K. Conrath, K. Jans, L. Brys, et al. 2005. Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing. Anal. Chem. 77: 7547-7555. https://doi.org/10.1021/ac051092j
  28. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  29. Schwede, T., J. Kopp, N. Guex, and M. C. Peitsch. 2003. SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res. 31: 3381. https://doi.org/10.1093/nar/gkg520
  30. Skov, L., K. Kragballe, C. Zachariae, E. R. Obitz, E. A. Holm, G. B. E. Jemec, et al. 2003. HuMax-CD4: A fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris. Arch. Dermatol. 139: 1433. https://doi.org/10.1001/archderm.139.11.1433
  31. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76: 4350. https://doi.org/10.1073/pnas.76.9.4350
  32. Truneh, A., D. Buck, D. R. Cassatt, R. Juszczak, S. Kassis, S. E. Ryu, D. Healey, R. Sweet, and Q. Sattentau. 1991. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J. Biol. Chem. 266: 5942.
  33. Tsygankov, A. Y., B. M. Broker, A. H. Guse, U. Meinke, E. Roth, C. Rossmann, and F. Emmrich. 1993. Preincubation with anti-CD4 influences activation of human T cells by subsequent co-cross-linking of CD4 with CD3. J. Leukocyte Biol. 54: 430.
  34. Whitlow, M. and D. Filpula. 1991. Single-chain Fv proteins and their fusion proteins. Methods 2: 97-105. https://doi.org/10.1016/S1046-2023(05)80209-9
  35. Wingren, C. and C. A. K. Borrebaeck. 2006. Antibody microarrays: Current status and key technological advances. OMICS 10: 411-427. https://doi.org/10.1089/omi.2006.10.411
  36. Yang, J., R. Chen, J. Wei, F. Zhang, Y. Zhang, L. Jia, et al. Production and characterization of a recombinant single-chain antibody against Hantaan virus envelop glycoprotein. Appl. Microbiol. Biotechnol. 86: 1067-1075.

Cited by

  1. Toward Low-Cost Affinity Reagents: Lyophilized Yeast-scFv Probes Specific for Pathogen Antigens vol.7, pp.2, 2011, https://doi.org/10.1371/journal.pone.0032042
  2. Construction and characterization of VL-VH tail-parallel genetically engineered antibodies against staphylococcal enterotoxins vol.61, pp.3, 2011, https://doi.org/10.1007/s12026-015-8623-7
  3. A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues vol.16, pp.None, 2011, https://doi.org/10.1186/s12885-016-2168-6
  4. Development of anti-CD47 single-chain variable fragment targeted magnetic nanoparticles for treatment of human bladder cancer vol.12, pp.6, 2011, https://doi.org/10.2217/nnm-2016-0302
  5. Expression and Characterization of a Single-Chain Variable Fragment against Human LOX-1 in Escherichia coli and Brevibacillus choshinensis vol.27, pp.5, 2011, https://doi.org/10.4014/jmb.1702.02007
  6. Immobilization of Recombinant Human Catalase on Gold and Silver Nanoparticles vol.185, pp.3, 2011, https://doi.org/10.1007/s12010-017-2682-2
  7. Isolation and characterization of malaria PfHRP2 specific V NAR antibody fragments from immunized shark phage display library vol.17, pp.None, 2011, https://doi.org/10.1186/s12936-018-2531-y